DM

David S. Millan

FT Forma Therapeutics: 38 patents #4 of 86Top 5%
Pfizer: 9 patents #561 of 5,153Top 15%
VH Valo Health: 5 patents #14 of 53Top 30%
VD Valo Early Discovery: 4 patents #17 of 30Top 60%
IC Icagen: 4 patents #38 of 88Top 45%
FT Foghorn Therapeutics: 3 patents #8 of 25Top 35%
VI Vertex Pharmaceuticals Incorporated: 2 patents #526 of 896Top 60%
📍 Stow, MA: #4 of 318 inventorsTop 2%
🗺 Massachusetts: #769 of 88,656 inventorsTop 1%
Overall (All Time): #37,528 of 4,157,543Top 1%
61
Patents All Time

Issued Patents All Time

Showing 26–50 of 61 patents

Patent #TitleCo-InventorsDate
10472342 Compounds and compositions for inhibition of FASN Kenneth W. Bair, David R. Lancia, Jr., Hongbin Li, James Loch, Wei Lu +3 more 2019-11-12
10472337 3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki +4 more 2019-11-12
10464909 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki +6 more 2019-11-05
10464910 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki +6 more 2019-11-05
10457652 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki +6 more 2019-10-29
10457655 Compounds and compositions for inhibition of FASN Kenneth W. Bair, David R. Lancia, Jr., Hongbin Li, James Loch, Wei Lu +3 more 2019-10-29
10450283 3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki +5 more 2019-10-22
10450286 Compounds and compositions for inhibition of FASN Kenneth W. Bair, David R. Lancia, Jr., Hongbin Li, James Loch, Wei Lu +3 more 2019-10-22
10450284 3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki +4 more 2019-10-22
10442776 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki +6 more 2019-10-15
10428031 3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki +5 more 2019-10-01
10421732 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki +6 more 2019-09-24
10421731 3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki +5 more 2019-09-24
10414738 3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki +5 more 2019-09-17
10399951 Compounds and compositions for inhibition of FASN Kenneth W. Bair, David R. Lancia, Jr., Hongbin Li, James Loch, Wei Lu +3 more 2019-09-03
10377769 Benzopiperazine compositions as BET bromodomain inhibitors Kenneth W. Bair, Torsten Herbertz, Goss S. Kauffman, Katherine J. Kayser-Bricker, George P. Luke +4 more 2019-08-13
10377726 3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki +4 more 2019-08-13
10336722 Tetrahydroquinoline compositions as BET bromodomain inhibitors Kenneth W. Bair, Torsten Herbertz, Goss S. Kauffman, Katherine J. Kayser-Bricker, George P. Luke +3 more 2019-07-02
10239845 3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki +4 more 2019-03-26
10214500 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki +6 more 2019-02-26
10214501 3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki +5 more 2019-02-26
10112915 3-aryl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki +4 more 2018-10-30
9630922 3-spiro-7-hydroxamic acid tetralins as HDAC inhibitors Pui Yee Ng, Heather Davis, Kenneth W. Bair, Aleksandra Rudnitskaya, Xiaozhang Zheng +3 more 2017-04-25
9422281 Benzopiperazine compositions as BET bromodomain inhibitors Kenneth W. Bair, Torsten Herbertz, Goss S. Kauffman, Katherine J. Kayser-Bricker, George P. Luke +4 more 2016-08-23
9388161 Tetrahydroquinoline compositions as BET bromodomain inhibitors Kenneth W. Bair, Torsten Herbertz, Goss S. Kauffman, Katherine J. Kayser-Bricker, George P. Luke +3 more 2016-07-12